Elsevier
+1
1096-3650
Bi-Monthly
14.5
1044-579X
1990
441865843000
United Kingdom
English
YES
Google Scholar
c.middendorp@elsevier.com
Seminars in Cancer Biology (YSCBI) is a review journal dedicated to keeping scientists informed of developments in the field of molecular oncology. Each issue is thematic in approach, devoted to an important topic of interest to cancer biologists, from the underlying genetic and molecular causes of cellular transformation and cancer to the molecular basis of potential therapies. Every issue is edited by a guest editor or editors, an internationally acknowledged expert(s) in the field and contains approximately eight to twelve authoritative invited reviews on different aspects of the subject area. The aim of each issue is to provide a coordinated, readable, and lively review of a selected area. The journal publishes topics including: Role of glycation in different types of cancer Immuno-Oncological Biomarkers Epigenetics: solid tumors and haematological malignancies Current Vision on target enzymes for cancer therapy Translational Cancer Genomics FOXO family in cancer Emerging trends in biomarker discovery: ease of prognosis and prediction in cancer Some chinks in Ras armor: novel cancer therapeutics on the horizon Conference - Cancer Stem Cells: impact on treatment
OJSCloud offers a complete, free setup to get you publishing.
Start Your Free Journal!Scholar9.com is a peer-review platform that hosts journals from across the globe. Please note that we do not own any of the journals hosted on the platform.
Our platform enables journal owners to send articles for peer review to users who have registered via https://scholar9.com/register and have consented to serve as reviewers for multiple journals. Additionally, we offer an indirect manuscript submission system for journals that are claimed and actively managed by their respective owners on Scholar9.com.
For accurate information about the indexing status of journals (in databases such as UGC CARE, Scopus, or Web of Science) and contact details, users must refer to the respective official websites.
Scholar9 is not responsible for indexing claims, manuscript acceptance/rejection, refunds of article processing charges, or any stage of the final publication process. Users are strongly advised to verify all information provided on the platform independently.
Scholar9.com disclaims liability for disputes related to indexing claims, publication decisions, or other journal-specific matters. Users are encouraged to contact the respective journal owners directly for detailed information and clarifications.